Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""hla-drb1"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 3737
Tytuł:
HLA-DRB1*04:05 is involved in the development of Vogt-Koyanagi-Harada disease-like immune-related adverse events in patients receiving immune checkpoint inhibitors.
Autorzy:
Takeuchi M; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan. .
Meguro A; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Nakamura J; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Chikagawa R; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Osada R; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Shibuya E; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Hasumi Y; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Yamada N; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Ishihara M; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Mizuki N; Department of Ophthalmology and Visual Science, Yokohama City University Graduate School of Medicine, 3-9 Fukuura, Kanazawa-ku, Yokohama, 236-0004, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Aug 21; Vol. 13 (1), pp. 13580. Date of Electronic Publication: 2023 Aug 21.
Typ publikacji:
Journal Article
MeSH Terms:
HLA-DRB1 Chains*/genetics
HLA-DRB1 Chains*/metabolism
Uveomeningoencephalitic Syndrome*/chemically induced
Uveomeningoencephalitic Syndrome*/genetics
Humans ; Immune Checkpoint Inhibitors ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Detection of the novel HLA allele, HLA-DRB1*08:112, identified in a Danish family.
Autorzy:
Plesner A; Department of Clinical Immunology - 7631, Rigshospitalet, Copenhagen University Hospital, Copenhagen N, Denmark.
Hald J; Department of Clinical Immunology - 7631, Rigshospitalet, Copenhagen University Hospital, Copenhagen N, Denmark.
Sengeløv H; Department of Hematology, Bone Marrow Transplant Unit, Rigshospitalet, Copenhagen University Hospital, Copenhagen N, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmark.
Bruunsgaard H; Department of Clinical Immunology - 7631, Rigshospitalet, Copenhagen University Hospital, Copenhagen N, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen N, Denmark.
Pokaż więcej
Źródło:
HLA [HLA] 2023 Feb; Vol. 101 (2), pp. 186-187. Date of Electronic Publication: 2022 Nov 07.
Typ publikacji:
Journal Article
MeSH Terms:
HLA-DRB1 Chains*/genetics
Humans ; Alleles ; Base Sequence ; Exons/genetics ; Denmark
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Cysteine carboxyethylation generates neoantigens to induce HLA-restricted autoimmunity.
Autorzy:
Zhai Y; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chen L; School of Medicine, Shanghai University, Shanghai 200444, China.
Zhao Q; Clinical Systems Biology Laboratories, Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, China.
Zheng ZH; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chen ZN; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Bian H; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Yang X; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Lu HY; Department of Occupational and Environmental Health and the Ministry of Education Key Lab of Hazard Assessment and Control in Special Operational Environment, School of Public Health, Fourth Military Medical University, Xi'an 710032, China.
Lin P; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chen X; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chen R; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Sun HY; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Fan LN; State Key Laboratory of Cancer Biology, Department of Pathology, Xijing Hospital and School of Basic Medicine, Fourth Military Medical University, Xi'an 710032, China.
Zhang K; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Wang B; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Sun XX; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Feng Z; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Zhu YM; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Zhou JS; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chen SR; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Zhang T; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chen SY; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chen JJ; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Zhang K; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Wang Y; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Chang Y; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Zhang R; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Zhang B; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Wang LJ; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Li XM; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
He Q; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Yang XM; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Nan G; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Xie RH; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Yang L; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Yang JH; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.; Clinical Systems Biology Laboratories, Translational Medicine Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou 450001, China.
Zhu P; Department of Clinical Immunology, Xijing Hospital, and Department of Cell Biology of National Translational Science Center for Molecular Medicine, Fourth Military Medical University, Xi'an 710032, China.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2023 Mar 17; Vol. 379 (6637), pp. eabg2482. Date of Electronic Publication: 2023 Mar 17.
Typ publikacji:
Journal Article
MeSH Terms:
Autoantibodies*/metabolism
Autoimmune Diseases*/genetics
Autoimmune Diseases*/metabolism
Cysteine*/metabolism
HLA-DRB1 Chains*/genetics
HLA-DRB1 Chains*/metabolism
Protein Processing, Post-Translational*
Integrin alpha2*/metabolism
Spondylitis, Ankylosing*/genetics
Spondylitis, Ankylosing*/metabolism
Animals ; Mice ; Autoimmunity/genetics ; Autoimmunity/immunology ; Mice, Transgenic ; Gastrointestinal Microbiome ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Comprehensive research on the distribution of HLA-DRB1 in Chinese populations.
Autorzy:
Fan B; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Huang X; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Zhang X; Pharmaceutical College & Key Laboratory of Pharmacology for Natural Products of Yunnan Province, Kunming Medical University, Kunming, China.
Huang L; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Yang Z; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Ma S; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Chu J; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Huang K; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Weng Y; The Second Affiliated Hospital of Kunming Medical University, Kunming, China.
Zhang L; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Lin K; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Sun H; The Department of Medical Genetics, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, China.
Pokaż więcej
Źródło:
HLA [HLA] 2023 Mar; Vol. 101 (3), pp. 239-248. Date of Electronic Publication: 2022 Dec 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
East Asian People*
HLA-DRB1 Chains*/genetics
Humans ; Alleles ; China ; Gene Frequency ; Haplotypes
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The novel HLA-DRB1*14:07:03 allele, identified by Sanger dideoxy nucleotide sequencing in a Chinese individual.
Autorzy:
Wu YB; Department of Hematology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Zheng ZZ; Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
Du KM; Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
An L; Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
Dai XP; Department of Hematology, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, The Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, China.
Pokaż więcej
Źródło:
HLA [HLA] 2023 Mar; Vol. 101 (3), pp. 294-296. Date of Electronic Publication: 2022 Nov 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HLA-DRB1 Chains*/genetics
Humans ; Alleles ; Base Sequence ; East Asian People ; Nucleotides
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigation of HLA susceptibility alleles and genotypes with hematological disease among Chinese Han population.
Autorzy:
Li YM; Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
Li YX; Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
Li DY; Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
Zhou Y; Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
An L; Shanghai Tissuebank Biotechnology Co., Ltd, Shanghai, China.
Yuan ZY; Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
Du KM; Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
Zheng ZZ; Shenzhen Tissuebank Precision Medicine Co., Ltd, Shenzhen, China.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 09; Vol. 19 (4), pp. e0281698. Date of Electronic Publication: 2024 Apr 09 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Histocompatibility Antigens Class I*/genetics
Hematologic Diseases*/genetics
Humans ; Gene Frequency ; Alleles ; HLA-DQ beta-Chains/genetics ; HLA-DRB1 Chains/genetics ; Genotype ; Haplotypes ; Genetic Predisposition to Disease
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Novel genetic variants of HLA gene associated with Thai Behcet's disease (BD) patients using next generation sequencing technology.
Autorzy:
Sornsamdang G; Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.; Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.
Shobana J; Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand.; Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.
Chanprapaph K; Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Chantratita W; Center for Medical Genomics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Chotewutmontri S; Faculty of Medicine and Public Health, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy, Bangkok, Thailand.
Limtong P; Division of Dermatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
O-Charoen P; Division of Allergy, Immunology, and Rheumatology, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Sukasem C; Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, 10400, Thailand. .; Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand. .; Pharmacogenomics and Precision Medicine, The Preventive Genomics & Family Check-Up Services Center, Bumrungrad International Hospital, Bangkok, Thailand. .; Department of Pharmacology and Therapeutics, MRC Centre for Drug Safety Science, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Apr 04; Vol. 14 (1), pp. 7967. Date of Electronic Publication: 2024 Apr 04.
Typ publikacji:
Journal Article
MeSH Terms:
Behcet Syndrome*/epidemiology
Female ; Humans ; HLA-DRB1 Chains/genetics ; High-Throughput Nucleotide Sequencing ; HLA-C Antigens/genetics ; Thailand ; HLA-B Antigens/genetics ; Alleles ; Technology ; Genetic Predisposition to Disease ; Aminopeptidases/genetics ; Minor Histocompatibility Antigens
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Machine learning-based prediction of rheumatoid arthritis with development of ACPA autoantibodies in the presence of non-HLA genes polymorphisms.
Autorzy:
Dudek G; Electrical Engineering Faculty, Czestochowa University of Technology, Czestochowa, Poland.; Faculty of Mathematics and Computer Science, University of Lodz, Lodz, Poland.; Centre for Data Analysis, Modelling and Computational Sciences, University of Lodz, Lodz, Poland.
Sakowski S; Faculty of Mathematics and Computer Science, University of Lodz, Lodz, Poland.; Centre for Data Analysis, Modelling and Computational Sciences, University of Lodz, Lodz, Poland.
Brzezińska O; Department of Rheumatology, Medical University of Lodz, Lodz, Poland.
Sarnik J; Department of Rheumatology, Medical University of Lodz, Lodz, Poland.
Budlewski T; Department of Rheumatology, Medical University of Lodz, Lodz, Poland.
Dragan G; Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, Lodz, Poland.
Poplawska M; Biobank, Department of Immunology and Allergy, Medical University of Lodz, Lodz, Poland.
Poplawski T; Department of Pharmaceutical Microbiology and Biochemistry, Medical University of Lodz, Lodz, Poland.
Bijak M; Biohazard Prevention Centre, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland.
Makowska J; Department of Rheumatology, Medical University of Lodz, Lodz, Poland.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Mar 22; Vol. 19 (3), pp. e0300717. Date of Electronic Publication: 2024 Mar 22 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Autoantibodies*/genetics
Arthritis, Rheumatoid*/diagnosis
Arthritis, Rheumatoid*/genetics
Humans ; Bayes Theorem ; Genetic Predisposition to Disease ; HLA-DRB1 Chains/genetics ; Polymorphism, Single Nucleotide ; Protein Tyrosine Phosphatase, Non-Receptor Type 22/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Contribution of HLA class I (A, B, C) and HLA class II (DRB1, DQA1, DQB1) alleles and haplotypes in exploring ethnic origin of central Tunisians.
Autorzy:
Ben Bnina A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Yessine A; Biochemistry Laboratory, Béchir Hamza Children's Hospital, Bab Saadoun Square, 1007, Tunis, Tunisia. .; Department of Educational Sciences, University of Jendouba, Higher Institute of Applied Studies in Humanity Le Kef, Kef, Tunisia. .
El Bahri Y; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Chouchene S; Hematology Laboratory, Fatouma Bourguiba Teaching Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Ben Lazrek N; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Mimouna M; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Mlika Z; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Messoudi A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.
Zellama D; Nephrology Department, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Sahtout W; Nephrology Department, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Medicine, University of Sousse, Sousse, Tunisia.
Bouatay A; Hematology Laboratory, Sahloul University Hospital, Sousse, Tunisia.; Faculty of Pharmacy, University of Monastir, Monastir, Tunisia.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2024 Feb 29; Vol. 17 (1), pp. 65. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Polymorphism, Genetic*
HLA-C Antigens*/genetics
North African People*
Humans ; Haplotypes ; HLA-DRB1 Chains/genetics ; Alleles ; Gene Frequency ; HLA-B Antigens/genetics ; HLA-A Antigens/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Investigating the genetic makeup of the major histocompatibility complex (MHC) in the United Arab Emirates population through next-generation sequencing.
Autorzy:
Marzouka NAD; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
Alnaqbi H; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
Al-Aamri A; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates.
Tay G; Division of Psychiatry, Faculty of Health and Medical Sciences, Medical School, The University of Western Australia, Crawley, WA, Australia.; School of Medical and Health Sciences, Edith Cowan University, Joondalup, WA, Australia.
Alsafar H; Center for Biotechnology, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates. .; College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates. .; Department of Biomedical Engineering, Khalifa University of Science and Technology, Abu Dhabi, United Arab Emirates. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Feb 09; Vol. 14 (1), pp. 3392. Date of Electronic Publication: 2024 Feb 09.
Typ publikacji:
Journal Article
MeSH Terms:
Histocompatibility Antigens Class I*/genetics
Histocompatibility Antigens Class II*/genetics
Humans ; United Arab Emirates ; Gene Frequency ; Major Histocompatibility Complex/genetics ; High-Throughput Nucleotide Sequencing ; Haplotypes ; Alleles ; HLA-DRB1 Chains/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Haplotype-dependent HLA-DRB1-DQB1 susceptibility to occult HBV infection in Xi'an Han population.
Autorzy:
Wang T; Shaanxi Province Blood Center, Xi'an, People's Republic of China.
Shen C; Shaanxi Province Blood Center, Xi'an, People's Republic of China.
Qi J; Shaanxi Province Blood Center, Xi'an, People's Republic of China.
Chen L; Shaanxi Province Blood Center, Xi'an, People's Republic of China.
Liu S; Shaanxi Province Blood Center, Xi'an, People's Republic of China.
Li H; Shaanxi Province Blood Center, Xi'an, People's Republic of China.
Pokaż więcej
Źródło:
Molecular genetics & genomic medicine [Mol Genet Genomic Med] 2023 Apr; Vol. 11 (4), pp. e2102. Date of Electronic Publication: 2023 Feb 27.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Hepatitis B*/genetics
Hepatitis B, Chronic*
HLA-DRB1 Chains*/genetics
HLA-DQ beta-Chains*/genetics
Humans ; Case-Control Studies ; Gene Frequency ; Haplotypes ; Hepatitis B virus
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HLA-DRB1*14:239, a novel HLA-DRB1 allele with one exonic mutation.
Autorzy:
Zhong XX; Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
Quan ZR; Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China.
Wu WD; Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
Luo SH; Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
Yuan R; Department of Clinical Laboratory, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong, China.
Pokaż więcej
Źródło:
HLA [HLA] 2022 Dec; Vol. 100 (6), pp. 651-653. Date of Electronic Publication: 2022 Aug 15.
Typ publikacji:
Journal Article
MeSH Terms:
HLA-DRB1 Chains*/genetics
Humans ; Alleles ; Base Sequence ; Exons/genetics ; Mutation
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HLA Polymorphisms and Clinical Manifestations in IgA Vasculitis.
Autorzy:
Held M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Stingl Jankovic K; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Sestan M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Sapina M; Department of Pediatrics, University Hospital Centre Osijek, Josip Juraj Strossmayer University of Osijek, Medical Faculty Osijek, 31000 Osijek, Croatia.
Kifer N; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Srsen S; Department of Pediatrics, University of Split School of Medicine, University Hospital Centre Split, 21000 Split, Croatia.
Frkovic M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Gagro A; Children's Hospital Zagreb, Medical Faculty Osijek, Josip Juraj Strossmayer University of Osijek, 10000 Zagreb, Croatia.
Grubic Z; Tissue Typing Centre, Clinical Department for Transfusion Medicine and Transplantation Biology, University Hospital Centre Zagreb, 10000 Zagreb, Croatia.
Jelusic M; Department of Pediatrics, University Hospital Centre Zagreb, University of Zagreb School of Medicine, 10000 Zagreb, Croatia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 10; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 10.
Typ publikacji:
Journal Article
MeSH Terms:
HLA Antigens*/genetics
IgA Vasculitis*/genetics
Genetic Predisposition to Disease*
Child ; Humans ; HLA-A Antigens ; HLA-B Antigens ; HLA-DRB1 Chains/genetics
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Extended genomic sequence of the HLA-DRB1*13:129 allele identified in a donor from the Gujarati population.
Autorzy:
Kumar P; Neuberg Centre for Genomics Medicine (NCGM), Neuberg Supratech Reference Laboratories (NSRL), Ahmedabad, India.
Thakker NC; Neuberg Centre for Genomics Medicine (NCGM), Neuberg Supratech Reference Laboratories (NSRL), Ahmedabad, India.
Chaudhary A; Neuberg Centre for Genomics Medicine (NCGM), Neuberg Supratech Reference Laboratories (NSRL), Ahmedabad, India.
Buch H; Neuberg Centre for Genomics Medicine (NCGM), Neuberg Supratech Reference Laboratories (NSRL), Ahmedabad, India.
Parek K; Neuberg Centre for Genomics Medicine (NCGM), Neuberg Supratech Reference Laboratories (NSRL), Ahmedabad, India.
Pokaż więcej
Źródło:
HLA [HLA] 2023 Jan; Vol. 101 (1), pp. 77-78. Date of Electronic Publication: 2022 Sep 20.
Typ publikacji:
Journal Article
MeSH Terms:
HLA-DRB1 Chains*/genetics
Humans ; Alleles
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Identification of the novel HLA allele, HLA-DRB1*14:50:02, in an individual from southern India.
Autorzy:
Tambe M; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
Pinto A; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
D'Silva SZ; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.
Singh M; Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Navi Mumbai, India.; Homi Bhabha National Institute, Mumbai, India.
Pokaż więcej
Źródło:
HLA [HLA] 2022 Oct; Vol. 100 (4), pp. 392-393. Date of Electronic Publication: 2022 Jun 30.
Typ publikacji:
Journal Article; Review
MeSH Terms:
HLA-DRB1 Chains*/genetics
Alleles ; Base Sequence ; Codon ; Exons/genetics ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The Influence of HLA Polymorphisms on the Severity of COVID-19 in the Romanian Population.
Autorzy:
Vică ML; Department of Cell and Molecular Biology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Legal Medicine Institute, 400006 Cluj-Napoca, Romania.
Dobreanu M; Emergency Clinical County Hospital, 540136 Târgu Mureș, Romania.; Department of Laboratory Medicine, 'George Emil Palade' University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureș, Romania.; Center for Advanced Medical and Pharmaceutical Research, 'George Emil Palade' University of Medicine, Pharmacy, Science and Technology, 540142 Târgu Mureș, Romania.
Curocichin G; Department of Family Medicine, 'Nicolae Testemițanu' State University of Medicine and Pharmacy, MD-2004 Chișinău, Moldova.
Matei HV; Department of Cell and Molecular Biology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Legal Medicine Institute, 400006 Cluj-Napoca, Romania.
Bâlici Ș; Department of Cell and Molecular Biology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Vușcan ME; Department of Cell and Molecular Biology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Legal Medicine Institute, 400006 Cluj-Napoca, Romania.
Chiorean AD; Department of Cell and Molecular Biology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Emergency Clinical Hospital for Children, 400370 Cluj-Napoca, Romania.
Nicula GZ; Department of Cell and Molecular Biology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Pavel Mironescu DC; Department of Cell and Molecular Biology, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.; Legal Medicine Institute, 400006 Cluj-Napoca, Romania.
Leucuța DC; Department of Medical Informatics and Biostatistics, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400349 Cluj-Napoca, Romania.
Teodoru CA; Clinical Surgical Department, Faculty of Medicine, 'Lucian Blaga' University of Sibiu, 550169 Sibiu, Romania.
Siserman CV; Legal Medicine Institute, 400006 Cluj-Napoca, Romania.; Department of Legal Medicine, 'Iuliu Hațieganu' University of Medicine and Pharmacy, 400006 Cluj-Napoca, Romania.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 22; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 22.
Typ publikacji:
Journal Article
MeSH Terms:
Genetic Predisposition to Disease*
COVID-19*/epidemiology
COVID-19*/genetics
Humans ; Romania/epidemiology ; Gene Frequency ; HLA-DRB1 Chains/genetics ; Genotype ; Haplotypes/genetics ; Alleles
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population.
Autorzy:
Kuebler B; Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.; Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
Alvarez-Palomo B; Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain.
Aran B; Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.; Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain.
Castaño J; Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain.; Advanced Therapy Platform, Hospital Sant Joan de Déu de Barcelona, Pg. de Sant Joan de Déu, 2, Espluges de Llobregat, 08950, Barcelona, Spain.
Rodriguez L; Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain.
Raya A; Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. .; Stem Cell Potency Group, Regenerative Medicine Program, Institut d´Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. .; Centre for Networked Biomedical Research On Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Madrid, Spain. .; Institució Catalana de Recerca I Estudis Avançats (ICREA), Barcelona, Spain. .
Querol Giner S; Advanced and Cell Therapy Service, Banc de Sang I Teixits, Edifici Dr. Frederic Duran I Jordà, Passeig de Taulat, 106-116, 08005, Barcelona, Spain. .; Transfusional Medicine Group, Vall d'Hebron Research Institute, Autonomous University of Barcelona (UAB), Barcelona, Spain. .
Veiga A; Pluripotent Stem Cell Group, Regenerative Medicine Program, Institut d'Investigació Biomédica de Bellvitge (IDIBELL), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. .; Program for Translation of Regenerative Medicine in Catalonia (P-[CMRC]), Hospital Duran I Reynals, Gran Via de L'Hospitalet, 199-203, L'Hospitalet de Llobregat, 08908, Barcelona, Spain. .
Pokaż więcej
Źródło:
Stem cell research & therapy [Stem Cell Res Ther] 2023 Dec 13; Vol. 14 (1), pp. 366. Date of Electronic Publication: 2023 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Induced Pluripotent Stem Cells*/metabolism
Humans ; HLA-DRB1 Chains/metabolism ; HLA Antigens/metabolism ; HLA-B Antigens/metabolism ; HLA-A Antigens/metabolism
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Human leukocyte antigen-DQ risk heterodimeric haplotypes of left ventricular dysfunction in cardiac sarcoidosis: an autoimmune view of its role.
Autorzy:
Yamamoto H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Miyashita Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. .; Department of Legal Medicine, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan. .
Minamiguchi H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Hosomichi K; Laboratory of Computational Genomics, School of Life Science, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo, 192-0392, Japan.
Yoshida S; Department of Cardiovascular Medicine, Kanazawa University Hospital, Kanazawa, Ishikawa, 920-8641, Japan.
Kioka H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Shinomiya H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Nagata H; Department of Cardiovascular Medicine, University of the Ryukyus Graduate School of Medicine, Nakagami, Okinawa, 903-0215, Japan.
Onoue K; Department of Cardiovascular Medicine, Nara Medical University, Kashihara, Nara, 634-8522, Japan.
Kawasaki M; Department of Cardiology, Osaka General Medical Center, Osaka, Osaka, 558-8558, Japan.
Kuramoto Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Nomura A; Innovative Research Center, Kanazawa University School of Medicine, Kanazawa, Ishikawa, 920-8641, Japan.
Toma Y; Department of Cardiovascular Medicine, University of the Ryukyus Graduate School of Medicine, Nakagami, Okinawa, 903-0215, Japan.
Watanabe T; Department of Cardiology, Osaka General Medical Center, Osaka, Osaka, 558-8558, Japan.
Yamada T; Department of Cardiology, Osaka General Medical Center, Osaka, Osaka, 558-8558, Japan.
Ishihara Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; The 1st Department of Oral and Maxillofacial Surgery, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Nagata M; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Department of Medical Ethics and Medical Genetics, Kyoto University Graduate School of Medicine, Kyoto, Kyoto, 606-8501, Japan.
Kato H; Department of Medical Biochemistry, Osaka University Graduate School of Medicine, Suita, Osaka, 565-0871, Japan.
Hakui H; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Saito Y; Department of Cardiovascular Medicine, Nara Prefecture Seiwa Medical Center, Nara, Nara, 636-0802, Japan.
Asano Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan. .; Department of Genomic Medicine, National Cerebral and Cardiovascular Center, Suita, Osaka, 564-8565, Japan. .
Sakata Y; Department of Cardiovascular Medicine, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 13; Vol. 13 (1), pp. 19767. Date of Electronic Publication: 2023 Nov 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Sarcoidosis*/genetics
Ventricular Dysfunction, Left*/genetics
Humans ; Haplotypes ; Stroke Volume ; HLA-DQ alpha-Chains/genetics ; HLA-DQ beta-Chains/genetics ; Ventricular Function, Left ; HLA-DQ Antigens/genetics ; Histocompatibility Antigens Class I/genetics ; Epitopes ; Peptides/genetics ; HLA-DRB1 Chains/genetics ; Gene Frequency ; Alleles ; Genetic Predisposition to Disease
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Association of HLA-DRB1*11 and HLA-DRB1*12 gene polymorphism with COVID-19 in Burkina Faso.
Autorzy:
Ouedraogo AR; Laboratoire de Morphologie et Organogénèse (LAMO), Université Joseph KI-ZERBO, UFR/SDS, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Traoré L; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.; Université Norbert ZONGO - Centre Universitaire de Manga, BP 376, Koudougou, Burkina Faso.
Ouattara AK; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.; Université Norbert ZONGO - Centre Universitaire de Manga, BP 376, Koudougou, Burkina Faso.
Ouedraogo AR; Laboratoire de Morphologie et Organogénèse (LAMO), Université Joseph KI-ZERBO, UFR/SDS, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Zongo SV; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Savadogo M; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Lallogo TD; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Sombie HK; Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA), P.O. Box 364, Ouagadougou 01, Burkina Faso.
Sorgho PA; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.; Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA), P.O. Box 364, Ouagadougou 01, Burkina Faso.
Ouedraogo TC; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Djigma FW; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso. .
Lamien AS; Laboratoire de Morphologie et Organogénèse (LAMO), Université Joseph KI-ZERBO, UFR/SDS, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Yonli AT; Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA), P.O. Box 364, Ouagadougou 01, Burkina Faso.
Lompo OM; Laboratoire de Morphologie et Organogénèse (LAMO), Université Joseph KI-ZERBO, UFR/SDS, Ouagadougou 01, 01 BP 7021, Burkina Faso.
Simporé J; Université Joseph KI-ZERBO, Laboratoire de Biologie Moléculaire et de Génétique (LABIOGENE), UFR/SVT, Ouagadougou 01, 01 BP 7021, Burkina Faso.; Centre de Recherche Biomoléculaire Pietro Annigoni (CERBA), P.O. Box 364, Ouagadougou 01, Burkina Faso.
Pokaż więcej
Źródło:
BMC medical genomics [BMC Med Genomics] 2023 Oct 16; Vol. 16 (1), pp. 246. Date of Electronic Publication: 2023 Oct 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
COVID-19*/genetics
Male ; Female ; Humans ; HLA-DRB1 Chains/genetics ; Gene Frequency ; Burkina Faso ; Cross-Sectional Studies ; SARS-CoV-2/genetics ; Polymorphism, Genetic ; Alleles ; Genetic Predisposition to Disease
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
HLA-DRB1 and cytokine polymorphisms in Brazilian patients with myelodysplastic syndromes and its association with red blood cell alloimmunization.
Autorzy:
Sirianni MFM; Departamento de Hemoterapia e Terapia Celular, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Sippert E; Hemocentro, Universidade Estadual de Campinas, Campinas, Brazil.
Blos B; Hemocentro to Serviço de Hemoterapia, Hospital de Clínicas de Porto Alegre, Porto Alegre, Brazil.
Gonçalves FRV; Departamento de Hemoterapia e Terapia Celular, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Hamerschlak N; Departamento de Hematologia e Oncologia, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Kutner J; Departamento de Hemoterapia e Terapia Celular, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Castilho L; Hemocentro, Universidade Estadual de Campinas, Campinas, Brazil.
Marti LC; IIEP-Departamento de Pesquisa Experimental, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Bonet-Bub C; Departamento de Hemoterapia e Terapia Celular, Hospital Israelita Albert Einstein, São Paulo, Brazil.
Pokaż więcej
Źródło:
Transfusion medicine (Oxford, England) [Transfus Med] 2022 Oct; Vol. 32 (5), pp. 394-401. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
Anemia, Hemolytic, Autoimmune*/genetics
HLA-DRB1 Chains*/genetics
Interleukin-17*/genetics
Interleukin-4*/genetics
Myelodysplastic Syndromes*/genetics
Myelodysplastic Syndromes*/therapy
Brazil ; Cytokines/genetics ; Erythrocytes ; Humans ; Isoantibodies ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 3737

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies